|
1) Choo QL, Kuo G, Weiner AJ, et al. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989; 244: 359-62
|
|
|
|
2) Mercer DF, Schiller DE, Elliott JF, et al. Hepatitis C virus replication in mice with chimeric human livers. Nat Med. 2001; 7: 927-33
|
|
|
|
|
|
3) de Jong YP, Rice CM, Ploss A. New horizons for studying human hepatotropic infections. J Clin Invest. 2010; 120: 650-3
|
|
|
|
|
|
4) Haid S, Windisch MP, Bartenschlager R, et al. Mouse-specific residues of claudin-1limit hepatitis C virus genotype 2a infection in a human hepatocyte cell line. J Virol. 2010; 84: 964-75
|
|
|
|
|
|
5) Bitzegeio J, Bankwitz D, Hueging K, et al. Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors. PLoS Pathog. 2010; 6: e1000978
|
|
|
|
|
|
6) Wakita T, Pietschmann T, Kato T, et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med. 2005; 11: 791-6
|
|
|
|
|
|
7) Yi M, Villanueva RA, Thomas DL, et al. Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A. 2006; 103: 2310-5
|
|
|
|
|
|
8) Pietschmann T, Zayas M, Meuleman P, et al. Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations. PLoS Pathog. 2009; 5: e1000475
|
|
|
|
|
|
9) Murayama A, Date T, Morikawa K, et al. The NS3 helicase and NS5B-to-3'X regions are important for efficient hepatitis C virus strain JFH-1 replication in Huh7 cells. J Virol. 2007; 81: 8030-40
|
|
|
|
|
|
10) Murayama A, Weng L, Date T, et al. RNA polymerase activity and specific RNA structure are required for efficient HCV replication in cultured cells. PLoS Pathog. 2010; 6: e1000885
|
|
|
|
|
|
11) Simister P, Schmitt M, Geitmann M, et al. Structural and functional analysis of hepatitis C virus strain JFH1 polymerase. J Virol. 2009; 83: 11926-39
|
|
|
|
|
|
12) Iro M, Witteveldt J, Angus AG, et al. A reporter cell line for rapid and sensitive evaluation of hepatitis C virus infectivity and replication. Antiviral Res. 2009; 83: 148-55
|
|
|
|
|
|
13) Jones CT, Catanese MT, Law LM, et al. Real-time imaging of hepatitis C virus infection using a fluorescent cell-based reporter system. Nat Biotechnol. 2010; 28: 167-71
|
|
|
|
|
|
14) Ploss A, Khetani SR, Jones CT, et al. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc Natl Acad Sci U S A. 2010; 107: 3141-45
|
|
|
|
|
|
15) Gastaminza P, Whitten-Bauer C, Chisari FV. Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection. Proc Natl Acad Sci U S A. 2010; 107: 291-6
|
|
|
|
|
|
16) Krey T, dʼAlayer J, Kikuti CM, et al. The disulfide bonds in glycoprotein E2 of hepatitis C virus reveal the tertiary organization of the molecule. PLoS Pathog. 2010; 6: e1000762
|
|
|
|
|
|
17) Gastaminza P, Dryden K, Boyd B, et al. Ultrastructural and biophysical characterization of hepatitis c virus particles produced in cell culture. J Virol. 2010 [Epub ahead of print]
|
|
|
|
|
|
18) Catanese MT, Ansuini H, Graziani R, et al. Role of scavenger receptor class B type I in hepatitis C virus entry: kinetics and molecular determinants. J Virol. 2010; 84: 34-43
|
|
|
|
|
|
19) Bankwitz D, Steinmann E, Bitzegeio J, et al. Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes. J Virol. 2010; 84: 5751-63
|
|
|
|
|
|
20) Evans MJ, von Hahn T, Tscherne DM, et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature. 2007; 446: 801-5
|
|
|
|
|
|
21) Ploss A, Evans MJ, Gaysinskaya VA, et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature. 2009; 457: 882-6
|
|
|
|
|
|
22) Rouillé Y, Helle F, Delgrange D, et al. Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus. J Virol. 2006; 80: 2832-41
|
|
|
|
|
|
23) Dreux M, Chisari FV. Autophagy proteins promote hepatitis C virus replication. Autophagy. 2009; 5: 1224-5
|
|
|
|
|
|
24) Dreux M, Gastaminza P, Wieland SF, et al. The autophagy machinery is required to initiate hepatitis C virus replication. Proc Natl Acad Sci U S A. 2009; 106: 14046-51
|
|
|
|
|
|
25) Tanida I, Fukasawa M, Ueno T, et al. Knockdown of autophagy-related gene decreases the production of infectious hepatitis C virus particles. Autophagy. 2009; 5: 937-45
|
|
|
|
|
|
26) Diamond DL, Syder AJ, Jacobs JM, et al. Temporal proteome and lipidome profiles reveal hepatitis C virus-associated reprogramming of hepatocellular metabolism and bioenergetics. PLoS Pathog. 2010; 6: e1000719
|
|
|
|
|
|
27) Li Q, Brass AL, Ng A, et al. A genome-wide genetic screen for host factors required for hepatitis C virus propagation. Proc Natl Acad Sci U S A. 2009; 106: 16410-5
|
|
|
|
|
|
28) Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science. 2010; 327: 198-201
|
|
|
|
|
|
29) Wozniak AL, Griffin S, Rowlands D, et al. Intracellular proton conductance of the hepatitis C virus p7 protein and its contribution to infectious virus production. PLoS Pathog. 2010; 6: e1001087
|
|
|
|
|
|
30) Masaki T, Suzuki R, Murakami K, et al. Interaction of hepatitis C virus nonstructural protein 5A with core protein is critical for the production of infectious virus particles. J Virol. 2008; 82: 7964-76
|
|
|
|
|
|
31) Backes P, Quinkert D, Reiss S, et al. Role of annexin A2 in the production of infectious hepatitis C virus particles. J Virol. 2010; 84: 5775-89
|
|
|
|
|
|
32) Kushima Y, Wakita T, Hijikata M. A disulfide-bonded dimer of the core protein of hepatitis C virus is important for virus-like particle production. J Virol. 2010; 84: 9118-27
|
|
|
|
|
|
33) Kaul A, Stauffer S, Berger C, et al. Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics. PLoS Pathog. 2009; 5: e1000546
|
|
|
|
|
|
34) Garaigorta U, Chisari FV. Hepatitis C virus blocks interferon effector function by inducing protein kinase R phosphorylation. Cell Host Microbe. 2009; 6: 513-22
|
|
|
|
|
|
35) Arnaud N, Dabo S, Maillard P, et al. Hepatitis C virus controls interferon production through PKR activation. PLoS One. 2010; 5: e10575
|
|
|
|
|